Moneycontrol PRO
you are here: HomeNewsIndia

Coronavirus state-wise tally November 30: Kerala's COVID-19 tally nears 6 lakh

With more than 18.2 lakh COVID-19 cases, Maharashtra has reported the highest number of infections, followed by Karnataka (8.8 lakh) and Andhra Pradesh (8.6 lakh).

November 30, 2020 / 10:00 AM IST
File image

File image

Kerala's COVID-19 tally neared the 6-lakh mark on November 29 after the state reported 5,643 new cases of the infectious disease in 24 hours. The state's tally stood at 5.99 lakh, including 2,223 deaths due to the disease.

With over 18.2 lakh cases, Maharashtra's COVID-19 tally remains the highest among Indian states and union territories, according to the Union Health Ministry's latest update.

Follow our LIVE blog for the latest updates of the coronavirus pandemic

The data was updated at 8.00 am on November 30 on the Ministry of Health and Family Welfare's website.

Here are the five most-affected states:

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

> Maharashtra -18,20,059 cases (includes recoveries, deaths and active cases)

> Karnataka - 8,83,899 cases

> Andhra Pradesh - 8,67,683 cases

> Tamil Nadu - 7,80,505 cases

> Kerala - 5,99,600 cases

India has recorded more than 94.3 lakh cases of the novel coronavirus and 1.37 lakh deaths. Of these, more than 4.46 lakh are active cases while over 88.4 lakh have recovered.

Below is the coronavirus cases/deaths state-wise tally:

S. No.
Name of State / UT
Active Cases*Cured/Discharged/Migrated*Deaths**
TotalChange since yesterdayCumulativeChange since yesterdayCumulativeChange since yesterday
1Andaman and Nicobar Islands1061345371961
2Andhra Pradesh83973174852298378769887
3Arunachal Pradesh851371536441543
8Dadra and Nagar Haveli and Daman and Diu221330832
13Himachal Pradesh8644+703072494463512
14Jammu and Kashmir50872510308249116855
19Madhya Pradesh1497471865211508325013
30Tamil Nadu11052217577501471117039
34Uttar Pradesh245756685095562618774224
35West Bengal244051324480323445837654
*(Including foreign Nationals)
**( more than 70% cases due to comorbidities )
#States wise distribution is subject to further verification and reconciliation
#Our figures are being reconciled with ICMR

Globally, more than 6.2 crore infections and over 14.5 lakh deaths have been reported due to the COVID-19 outbreak, according to the Reuters tally.

Click here for Moneycontrol’s full coverage of the coronavirus pandemic

Moneycontrol News
first published: Nov 30, 2020 10:00 am